- 237
- 2 160 047
BrightFocus Foundation
United States
Приєднався 16 січ 2013
BrightFocus Foundation is a nonprofit organization supporting research and providing public education to help eradicate Alzheimer's disease, macular degeneration, and glaucoma. Through our flagship programs - Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research - we have invested nearly $300 million in research grants, catalyzing thousands of scientific breakthroughs, life-enhancing treatments, and diagnostic tools.
To learn more, visit brightfocus.org.
To learn more, visit brightfocus.org.
Kisunla: New Hope for Alzheimer's (Zoom In on Dementia & Alzheimer's - 60)
The FDA recently approved Kisunla (donanemab), a new Alzheimer’s medication shown to slow the progression of the disease.
▶️ Watch this #Short sneak peek from our July Zoom In on Dementia & Alzheimer’s episode featuring leading expert, Dr. Paul Aisen of [@] Keck School of Medicine about Kisunla.
To learn how the drug works, for whom, side effects, what it costs, whether it’s covered by insurance, and how it compares with other new Alzheimer’s medicines, check out our full episode here: bit.ly/ZoomInAlz.
Subscribe @BrightFocus.org
#Alzheimers #Kisunla #Donanemab #Health #HealthNews #Dementia #Alz #Aging #Medicine #AlzheimersAwareness
▶️ Watch this #Short sneak peek from our July Zoom In on Dementia & Alzheimer’s episode featuring leading expert, Dr. Paul Aisen of [@] Keck School of Medicine about Kisunla.
To learn how the drug works, for whom, side effects, what it costs, whether it’s covered by insurance, and how it compares with other new Alzheimer’s medicines, check out our full episode here: bit.ly/ZoomInAlz.
Subscribe @BrightFocus.org
#Alzheimers #Kisunla #Donanemab #Health #HealthNews #Dementia #Alz #Aging #Medicine #AlzheimersAwareness
Переглядів: 1 020
Відео
Kisunla: New Hope for Alzheimer's (Zoom In on Dementia & Alzheimer's - 30)
Переглядів 3,2 тис.12 годин тому
The FDA recently approved Kisunla (donanemab), a new Alzheimer’s medication shown to slow the progression of the disease. ▶️ Watch this #Short sneak peek from our July Zoom In on Dementia & Alzheimer’s episode featuring leading expert, Dr. Paul Aisen of [@] Keck School of Medicine about Kisunla. To learn how the drug works, for whom, side effects, what it costs, whether it’s covered by insuranc...
BrightFocus Foundation: Cure in Mind. Cure in Sight
Переглядів 11114 днів тому
BrightFocus Foundation funds exceptional scientific research worldwide to defeat Alzheimer’s, macular degeneration, and glaucoma - diseases of mind and sight that impact more than 300 million people worldwide. Through its flagship research programs - Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research - the Foundation has awarded nearly $300 million in gr...
How Diet and Nutrition Impact Macular Degeneration
Переглядів 6 тис.28 днів тому
What are the best foods to lower your risk of developing age-related macular degeneration (AMD)? If you already have AMD, can changing your diet slow the progression of the disease? This Macular Chat episode will explore how diet and nutrition influence the risk and progression of AMD and discuss the vital role that the gut microbiome plays in overall human health. Learn which foods to eat more...
The HOPE Study: Testing a Non-invasive, Light and Sound Stimulation Treatment for Alzheimer’s
Переглядів 17 тис.Місяць тому
Join Cognito Therapeutics CEO, Brent Vaughan to talk about the pivotal HOPE Study, currently open for recruitment, which uses an investigational medical device consisting of headphones and eyewear to deliver sensory stimulation treatment in the comfort of people’s homes. The HOPE Study explores if this approach will potentially prove to slow the progression of mild to moderate Alzheimer’s disea...
The New Alzheimer’s Drug: What is Kisunla?
Переглядів 22 тис.Місяць тому
On July 2, 2024, the U.S. Food and Drug Administration approved Kisunla (donanemab), a new Alzheimer’s medication shown to slow the progression of the disease. Join our conversation with Dr. Paul Aisen as he details how the drug works, for whom, side effects, what it costs, whether it’s covered by insurance, and how it compares with other new Alzheimer’s medicines. Zoom In on Dementia & Alzheim...
Latest Updates on Glaucoma Eye Drops
Переглядів 9 тис.Місяць тому
Join us for a conversation with Dr. Natasha Nayak Kolomeyer, a glaucoma specialist and ophthalmologist at Wills Eye Hospital. Dr. Kolomeyer will discuss various types of eye drops used in glaucoma treatment, how they work, potential side effects, and tips for managing challenges associated with their use. We’ll also discuss new developments in glaucoma eye drops and how long these treatments ar...
Childhood Glaucoma
Переглядів 6 тис.2 місяці тому
Learn about the different types of childhood glaucoma, including primary congenital, infantile, and juvenile glaucoma. Guest expert Dr. Javaneh Abassian will explain the role of genetics and associated systemic diseases, trauma-induced cases, and diagnosis and treatment. Glaucoma Chats are free, monthly audio discussions with glaucoma specialists and other eye care professionals. Learn tips for...
Brain Health Research: Participate From Your Home
Переглядів 24 тис.2 місяці тому
Are you between 18-95 years old and interested in brain health? Learn from leading scientists about two research opportunities from the Emory Healthy Aging Study and the NeuroQuest Study. Zoom In on Dementia & Alzheimer's is a monthly virtual discussion series with world-class expert research scientists to keep you informed about the latest breakthroughs and findings in the field-from treatment...
The Role of Genetics in Early Diagnosis and Treatment of Dementia
Переглядів 39 тис.2 місяці тому
Alzheimer’s is associated with several genetic signatures that can mean an increased risk of developing various forms of dementia. If you learn about your specific genetic makeup early enough - before symptoms of memory loss begin - could you benefit from this knowledge? Would you be eligible for specific types of treatment? Tune in to learn about the importance of understanding your genetic ri...
Geographic Atrophy: Your Questions Answered
Переглядів 1522 місяці тому
Geographic atrophy is an advanced and severe form of dry age-related macular degeneration that can lead to permanent vision loss. Guest expert Dr. Philip Niles will share what you need to know about identifying, preventing, and treating geographic atrophy and delve into the landscape of available treatments. Macular Chats is a series of free monthly discussions from Macular Degeneration Researc...
Exploring Artificial Intelligence and Glaucoma: Challenges, Opportunities, and Hope
Переглядів 10 тис.3 місяці тому
In this episode of Glaucoma Chats, we discussed artificial intelligence and glaucoma. Can artificial intelligence reimagine the way we detect and diagnose glaucoma? Discover the innovative ways scientists and healthcare professionals are leveraging this technology (and the challenges that lie ahead) with expert glaucoma specialists Dr. Atalie Thompson and guest moderator, Dr. Jullia Rosdahl. Gl...
Resources to Help You Live Well with Age-Related Macular Degeneration
Переглядів 11 тис.3 місяці тому
This episode of Macular Chats focused on resources and support for people who have been diagnosed with macular degeneration. After a macular degeneration diagnosis, the best way to adapt to vision loss is to learn new ways of doing things. Ed Haines discussed the resources available from the organization Hadley, which provides practical, social, and emotional support to older adults adjusting t...
Artificial Intelligence and Alzheimer’s: How AI Is Revolutionizing Dementia Detection and Treatment
Переглядів 28 тис.3 місяці тому
This episode of Zoom in on Dementia & Alzheimer's focused on artificial intelligence and Alzheimer's disease. This year, the Food and Drug Administration approved an artificial intelligence (AI) tool called BrainSee to predict the likelihood of Alzheimer’s progression using brain scans. Are AI programs the next frontier in forecasting, understanding, and managing Alzheimer’s? Dr. Timothy Hohman...
Glaucoma Imaging: Trends in Detection and Diagnosis
Переглядів 9 тис.4 місяці тому
Glaucoma Imaging: Trends in Detection and Diagnosis
When Dementia Strikes in Middle Age: The Challenges of Early-Onset Alzheimer's Disease
Переглядів 32 тис.4 місяці тому
When Dementia Strikes in Middle Age: The Challenges of Early-Onset Alzheimer's Disease
What You Need to Know About Cataracts and Macular Degeneration
Переглядів 8 тис.4 місяці тому
What You Need to Know About Cataracts and Macular Degeneration
Building Connection and Community: Take Charge of Your Glaucoma Diagnosis
Переглядів 12 тис.5 місяців тому
Building Connection and Community: Take Charge of Your Glaucoma Diagnosis
Can Non-Drug Interventions Really Reduce Your Risk of Alzheimer’s?
Переглядів 16 тис.5 місяців тому
Can Non-Drug Interventions Really Reduce Your Risk of Alzheimer’s?
Cataracts and Glaucoma What You Should Know in 2024
Переглядів 10 тис.6 місяців тому
Cataracts and Glaucoma What You Should Know in 2024
Maintaining Emotional Wellness: Living with Age-Related Macular Degeneration
Переглядів 10 тис.6 місяців тому
Maintaining Emotional Wellness: Living with Age-Related Macular Degeneration
The Stages of Alzheimer’s - How Does Dementia Really Progress?
Переглядів 34 тис.6 місяців тому
The Stages of Alzheimer’s - How Does Dementia Really Progress?
The Eye Exam for Glaucoma Six Common Tests
Переглядів 13 тис.7 місяців тому
The Eye Exam for Glaucoma Six Common Tests
Managing Wet Age-Related Macular Degeneration: Basics and Treatment
Переглядів 977 місяців тому
Managing Wet Age-Related Macular Degeneration: Basics and Treatment
Alzheimer’s Clinical Trials 2024: The Inside Story with Dr. Jeffrey Cummings
Переглядів 39 тис.7 місяців тому
Alzheimer’s Clinical Trials 2024: The Inside Story with Dr. Jeffrey Cummings
Macular Degeneration Research Update on Research Funding
Переглядів 9 тис.7 місяців тому
Macular Degeneration Research Update on Research Funding
Patient Stories About Geographic Atrophy
Переглядів 9 тис.7 місяців тому
Patient Stories About Geographic Atrophy